On February 8th and 9th 2023, we engaged in a scientific meeting for WP1, WP2, and WP3 partners in Strasbourg, France. Graciously hosted by our partners in QST.lab at the University of Strasbourg, we discussed the details of quantitative sensory testing element of these work packages, which will directly inform our first PAINLESS clinical study. This clinical study focuses on developing a predictive tool that can tell us who is likely to experience cancer-related pain. Partners in attendance included QST.Lab, SERGAS, TECHNION, the University of Santiago de Compostela, and the University of Aalborg. We were also joined remotely by our colleagues in Mentalab and Universitätsmedizin Göttingen.
Based on this productive meeting, we expect to make clear advances by starting our first clinical study for PAINLESS shortly- stay tuned and have a look at the images captured at the meeting below!
